In an alternative approach to directly study protein expression in body fluids or tumor tissues (Psyrri et al. 2007) a novel method of compartmentalized was developed for in situ protein analysis so as to determine the prognostic value of the p53 biomarker in ovarian cancer. The gene discussed is TP53; the disease is ovarian carcinoma.